Key points are not available for this paper at this time.
Biomolecular simulation is a diverse and growing area of research, making important contributions to structural biology and pharmaceutical research Within the community there are a several significant and widely used software packages that have evolved from within various research groups over the past 20 or more years. For example, the molecular dynamics packages AMBER Since different software packages were developed independently, interoperability between them is poor. In large part this is the result of major differences in the supported file formats, which makes it difficult to translate the inputs and outputs of one program to another. As a consequence, expertise in one package doesn't immediately apply to another, making it hard to share methodology and knowledge between different research communities, as evidenced, for instance, by a recent study on reproducibility of relative hydration free energies across simulation packages The issue is compounded by the increasing use of biomolecular simulations as components of larger scientific workflows for bioengineering or computer-aided drug design purposes. A lack of interoperability leads to brittle workflows, poor reproducibility, and lock in to specific software that hinders dissemination of biomolecular simulation methodologies to other communities.
Hedges et al. (Fri,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: